AbCellera Biologics Inc. (ABCL) NASDAQ

$4.49 0.20 (4.66%)

Market Cap: $1.31B

As of 03/28/24 04:00 PM EDT. Market closed.

(ABCL)

AbCellera Biologics Inc. (ABCL)
NASDAQ

$4.49
0.20 (4.66%)

Market Cap: $1.31B

As of 03/28/24 04:00 PM EDT. Market closed.

Add to Portfolio

abcellera is a canadian biotechnology company focused on accelerating the discovery of monoclonal antibody (mabs) therapeutics. antibodies are molecules that are naturally produced by the immune system of humans or animals to fight off infection and disease. the unique property of antibodies is that they can specifically recognize and target diseased cells or pathogens, making them precise and ... read more

abcellera is a canadian biotechnology company focused on accelerating the discovery of monoclonal antibody (mabs) therapeutics. antibodies are molecules that are naturally produced by the immune system of humans or animals to fight off infection and disease. the unique property of antibodies is that they can specifically recognize and target diseased cells or pathogens, making them precise and highly effective drugs with low side effects for the treatment of cancer, autoimmune disorders and infections. the immune system is capable of making billions to trillions of unique antibodies, each produced by a single immune cell. of these, only a select few are suitable for therapeutic applications. finding these rare antibodies presents a major roadblock in the development of new therapeutics. abcellera addresses this bottleneck by using microfluidic technology for the rapid and high-throughput analysis of antibodies directly from single cells. abcellera is a spinoff from dr. carl hansen’ read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carl L.G. Hansen
Full Time Employees
459
URL
Address
2215 Yukon Street, BC, Vancouver, V5Y 0A1.
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carl L.G. Hansen
Full Time Employees
459
Address
2215 Yukon Street, BC, Vancouver, V5Y 0A1.
PRICE CHART FOR ABCELLERA BIOLOGICS INC
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$4.62
Previous Close
$4.29
Days Range
$4.27 - $4.51
52 week range
$3.87 - $8.05
Volume
929,055
Avg. Volume (30 days)
1,368,661
Market Cap
$1.31B
Dividend Yield
-
P/E
(8.98)
Shares Outstanding
292,782,152
Open
$4.62
Previous Close
$4.29
Days Range
$4.27 - $4.51
52 week range
$3.87 - $8.05
Volume
929,055
Avg. Volume (30 days)
1,368,661
Market Cap
$1.31B
Dividend Yield
-
P/E
(8.98)
Shares Outstanding
292,782,152
FINANCIAL STATEMENTS FOR ABCELLERA BIOLOGICS INC
LOADING...

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR ABCELLERA BIOLOGICS INC
OwnerRelationshipDateTransactionCost# SharesValue($)Total SharesForm 4
Hansen Carl L. G.Chief Executive OfficerFeb 26, 2024 Option Exercise$2.7056,125151,538729,625Feb 27, 2024, 02:12 PM
Hansen Carl L. G.Chief Executive OfficerNov 23, 2023 Option Exercise$2.7056,125151,538673,500Nov 27, 2023, 04:45 PM
Montalbano John S.DirectorNov 08, 2023 Buy$4.4610,00044,60086,000Nov 08, 2023, 03:29 PM
Montalbano John S.DirectorNov 06, 2023 Buy$4.6420,00092,80076,000Nov 08, 2023, 03:29 PM
Hayden Michael RDirectorSep 22, 2023 Buy$4.9120,00098,2001,323,397Sep 26, 2023, 12:26 PM
Lecault VeroniqueChief Operating OfficerSep 12, 2023 Buy$5.1920,000103,8002,040,122Sep 14, 2023, 04:38 PM
Hansen Carl L. G.Chief Executive OfficerAug 24, 2023 Option Exercise$2.7056,125151,538617,375Aug 25, 2023, 01:57 PM
Hayden Michael RDirectorAug 08, 2023 Buy$5.9030,000177,0001,303,397Aug 09, 2023, 12:22 PM
Hansen Carl L. G.Chief Executive OfficerMay 26, 2023 Option Exercise$2.7056,125151,538561,250May 30, 2023, 01:14 PM
Booth AndrewChief Financial OfficerMay 26, 2023 Buy$6.8514,50099,325153,000May 26, 2023, 02:53 PM
Thermopylae Holdings Ltd.10% OwnerMay 26, 2023 Buy$6.52153,000997,72856,012,493May 26, 2023, 02:50 PM
Lecault VeroniqueChief Operating OfficerMay 05, 2023 Option Exercise$0.19250,00047,5002,020,122May 09, 2023, 03:02 PM
Hansen Carl L. G.Chief Executive OfficerFeb 22, 2023 Option Exercise$2.7056,125151,538505,125Feb 23, 2023, 04:33 PM
Booth AndrewChief Financial OfficerDec 20, 2022 Option Exercise$0.1950,0009,500188,500Dec 22, 2022, 02:31 PM
Thermopylae Holdings Ltd.10% OwnerDec 16, 2022 Buy$10.1085,102859,24955,859,493Dec 20, 2022, 10:18 AM
Hansen Carl L. G.Chief Executive OfficerNov 18, 2022 Option Exercise$2.7056,125151,538449,000Nov 21, 2022, 09:36 PM
Thermopylae Holdings Ltd.10% OwnerAug 19, 2022 Buy$11.46200,0002,292,46055,844,391Aug 22, 2022, 03:27 PM
Hansen Carl L. G.Chief Executive OfficerAug 18, 2022 Option Exercise$2.7056,125151,538392,875Aug 22, 2022, 03:09 PM
Thermopylae Holdings Ltd.10% OwnerJun 14, 2022 Buy$8.059,17373,84255,644,391Jun 15, 2022, 01:14 PM
Thermopylae Holdings Ltd.10% OwnerJun 13, 2022 Buy$8.0354,915441,06655,635,218Jun 15, 2022, 01:14 PM
Thermopylae Holdings Ltd.10% OwnerJun 06, 2022 Buy$7.5064,545483,96555,580,303Jun 08, 2022, 03:32 PM
Hansen Carl L. G.Chief Executive OfficerMay 18, 2022 Option Exercise$2.7056,125151,538336,750May 19, 2022, 01:17 PM
Lecault VeroniqueChief Operating OfficerMay 16, 2022 Buy$6.34200,0001,267,7801,770,122May 17, 2022, 03:07 PM
Thermopylae Holdings Ltd.10% OwnerMay 13, 2022 Buy$7.26300,0002,176,53055,515,758May 17, 2022, 03:04 PM
Thermopylae Holdings Ltd.10% OwnerMay 12, 2022 Buy$6.411,408,4689,021,80155,215,758May 16, 2022, 02:14 PM
Booth AndrewChief Financial OfficerMay 12, 2022 Buy$5.7985,000492,150138,500May 16, 2022, 02:13 PM
Montalbano John S.DirectorMar 04, 2022 Buy$8.5410,00085,40056,000Mar 04, 2022, 04:51 PM
Montalbano John S.DirectorMar 01, 2022 Buy$9.0520,000181,00046,000Mar 03, 2022, 12:06 PM
Lecault VeroniqueChief Operating OfficerFeb 28, 2022 Buy$8.66230,7891,998,6331,570,122Mar 01, 2022, 07:49 PM
Hansen Carl L. G.Chief Executive OfficerFeb 22, 2022 Option Exercise$2.7056,125151,538280,625Feb 25, 2022, 01:50 PM
Booth AndrewChief Financial OfficerDec 10, 2021 Option Exercise$0.32500,000160,000553,500Dec 10, 2021, 05:00 PM
Lecault VeroniqueChief Operating OfficerDec 08, 2021 Option Exercise$0.19250,00047,5001,589,333Dec 09, 2021, 05:49 PM
Lo AndrewDirectorDec 03, 2021 Buy$14.0286,9381,218,87186,938Dec 07, 2021, 03:17 PM
Lecault VeroniqueChief Operating OfficerNov 30, 2021 Option Exercise$0.1983,33315,8331,422,666Dec 03, 2021, 05:47 PM
Lecault VeroniqueChief Operating OfficerNov 30, 2021 Option Exercise$14.9683,3331,246,6621,422,666Dec 02, 2021, 02:16 PM
Hansen Carl L. G.Chief Executive OfficerNov 18, 2021 Option Exercise$15.03224,5003,374,235224,500Nov 22, 2021, 05:03 PM
Booth AndrewChief Financial OfficerNov 11, 2021 Buy$14.6114,000204,540130,959Nov 15, 2021, 06:05 AM
Booth AndrewChief Financial OfficerNov 11, 2021 Buy$14.7453,500788,59053,500Nov 15, 2021, 06:05 AM
Thermopylae Holdings Ltd.10% OwnerNov 11, 2021 Buy$14.76202,9602,995,91355,807,290Nov 15, 2021, 06:05 AM
Hayden Michael RDirectorSep 13, 2021 Option Exercise$17.73270,0004,787,1001,273,397Sep 15, 2021, 04:12 PM
Falconer EsterChief Technology OfficerSep 01, 2021 Option Exercise$16.89875,00014,778,749875,000Sep 03, 2021, 04:18 PM
HAMER JOHNDirectorSep 01, 2021 Sale$16.93137,3512,325,352128,862Sep 02, 2021, 06:12 PM
HAMER JOHNDirectorAug 31, 2021 Sale$16.95162,6492,756,901266,213Sep 02, 2021, 06:12 PM
Montalbano John S.DirectorAug 16, 2021 Buy$17.236,000103,38026,000Aug 17, 2021, 05:47 PM
Hayden Michael RDirectorJun 22, 2021 Sale$25.50100,0002,550,0001,003,397Jun 22, 2021, 06:50 PM
Thermopylae Holdings Ltd.10% OwnerJun 09, 2021 Sale$24.035,598,420134,530,03655,604,330Jun 10, 2021, 05:14 PM
Hansen Carl L. G.Chief Executive OfficerJun 09, 2021 Sale$24.136,000,000144,770,32655,604,330Jun 10, 2021, 05:11 PM
Lecault VeroniqueChief Operating OfficerJun 09, 2021 Sale$25.501,000,00025,500,000273,630Jun 10, 2021, 05:01 PM
Stimart TrynChief Legal OfficerJun 09, 2021 Sale$25.501,000,00025,500,000250Jun 10, 2021, 05:01 PM
Falconer EsterChief Technology OfficerJun 09, 2021 Sale$25.501,000,00025,500,0000Jun 10, 2021, 05:00 PM
Stimart TrynChief Legal OfficerJun 07, 2021 Option Exercise$0.811,000,000815,0001,000,250Jun 09, 2021, 08:30 PM
Booth AndrewChief Financial OfficerJun 07, 2021 Option Exercise$0.251,200,000306,0001,200,000Jun 09, 2021, 08:30 PM
Falconer EsterChief Technology OfficerMar 19, 2021 Option Exercise$0.031,000,00034,3001,000,000Apr 23, 2021, 08:00 PM
THIEL PETERDirectorDec 15, 2020 Buy$20.003,000,00060,000,00010,179,880Dec 17, 2020, 08:38 PM
Montalbano John S.DirectorDec 15, 2020 Buy$20.005,000100,0005,000Dec 17, 2020, 08:30 PM
Montalbano John S.DirectorDec 15, 2020 Buy$20.0020,000400,00020,000Dec 17, 2020, 08:30 PM
Lecault VeroniqueChief Operating OfficerDec 15, 2020 Buy$20.006,000120,0001,006,000Dec 17, 2020, 08:30 PM
Lecault VeroniqueChief Operating OfficerDec 15, 2020 Buy$20.0017,000340,00061,580Dec 17, 2020, 08:30 PM
Hayden Michael RDirectorNov 06, 2020 Option Exercise$0.33270,00089,100985,750Dec 17, 2020, 08:30 PM
Hayden Michael RDirectorDec 15, 2020 Buy$20.0073,6651,473,300118,245Dec 17, 2020, 08:30 PM
Stimart TrynChief Legal OfficerDec 15, 2020 Buy$20.002505,000250Dec 17, 2020, 08:30 PM
Stimart TrynChief Legal OfficerDec 15, 2020 Buy$20.002505,000250Dec 17, 2020, 08:30 PM
Load More Insider Transactions
Buy Sale Option Exercise
OwnerRelationshipDateValue($)
Hansen Carl L. G.Chief Executive Officer02/26/2024151,538
Hansen Carl L. G.Chief Executive Officer11/23/2023151,538
Montalbano John S.Director11/08/202344,600
Montalbano John S.Director11/06/202392,800
Hayden Michael RDirector09/22/202398,200
Lecault VeroniqueChief Operating Officer09/12/2023103,800
Hansen Carl L. G.Chief Executive Officer08/24/2023151,538
Hayden Michael RDirector08/08/2023177,000
Hansen Carl L. G.Chief Executive Officer05/26/2023151,538
Booth AndrewChief Financial Officer05/26/202399,325
Thermopylae Holdings Ltd.10% Owner05/26/2023997,728
Lecault VeroniqueChief Operating Officer05/05/202347,500
Hansen Carl L. G.Chief Executive Officer02/22/2023151,538
Booth AndrewChief Financial Officer12/20/20229,500
Thermopylae Holdings Ltd.10% Owner12/16/2022859,249
Hansen Carl L. G.Chief Executive Officer11/18/2022151,538
Thermopylae Holdings Ltd.10% Owner08/19/20222,292,460
Hansen Carl L. G.Chief Executive Officer08/18/2022151,538
Thermopylae Holdings Ltd.10% Owner06/14/202273,842
Thermopylae Holdings Ltd.10% Owner06/13/2022441,066
Thermopylae Holdings Ltd.10% Owner06/06/2022483,965
Hansen Carl L. G.Chief Executive Officer05/18/2022151,538
Lecault VeroniqueChief Operating Officer05/16/20221,267,780
Thermopylae Holdings Ltd.10% Owner05/13/20222,176,530
Thermopylae Holdings Ltd.10% Owner05/12/20229,021,801
Booth AndrewChief Financial Officer05/12/2022492,150
Montalbano John S.Director03/04/202285,400
Montalbano John S.Director03/01/2022181,000
Lecault VeroniqueChief Operating Officer02/28/20221,998,633
Hansen Carl L. G.Chief Executive Officer02/22/2022151,538
Booth AndrewChief Financial Officer12/10/2021160,000
Lecault VeroniqueChief Operating Officer12/08/202147,500
Lo AndrewDirector12/03/20211,218,871
Lecault VeroniqueChief Operating Officer11/30/202115,833
Lecault VeroniqueChief Operating Officer11/30/20211,246,662
Hansen Carl L. G.Chief Executive Officer11/18/20213,374,235
Booth AndrewChief Financial Officer11/11/2021204,540
Booth AndrewChief Financial Officer11/11/2021788,590
Thermopylae Holdings Ltd.10% Owner11/11/20212,995,913
Hayden Michael RDirector09/13/20214,787,100
Falconer EsterChief Technology Officer09/01/202114,778,749
HAMER JOHNDirector09/01/20212,325,352
HAMER JOHNDirector08/31/20212,756,901
Montalbano John S.Director08/16/2021103,380
Hayden Michael RDirector06/22/20212,550,000
Thermopylae Holdings Ltd.10% Owner06/09/2021134,530,036
Hansen Carl L. G.Chief Executive Officer06/09/2021144,770,326
Lecault VeroniqueChief Operating Officer06/09/202125,500,000
Stimart TrynChief Legal Officer06/09/202125,500,000
Falconer EsterChief Technology Officer06/09/202125,500,000
Stimart TrynChief Legal Officer06/07/2021815,000
Booth AndrewChief Financial Officer06/07/2021306,000
Falconer EsterChief Technology Officer03/19/202134,300
THIEL PETERDirector12/15/202060,000,000
Montalbano John S.Director12/15/2020100,000
Montalbano John S.Director12/15/2020400,000
Lecault VeroniqueChief Operating Officer12/15/2020120,000
Lecault VeroniqueChief Operating Officer12/15/2020340,000
Hayden Michael RDirector11/06/202089,100
Hayden Michael RDirector12/15/20201,473,300
Stimart TrynChief Legal Officer12/15/20205,000
Stimart TrynChief Legal Officer12/15/20205,000
Load More Insider Transactions
FUNDS WITH A POSITION IN ABCELLERA BIOLOGICS INC
Fund# Shares Owned% of Portfolio% ChangeInvesting Style
BAKER BROS. ADVISORS LP22,909,7531.49%10.34%Other
CAPITAL WORLD INVESTORS8,351,2930.00848%-0.82%Growth At A Reasonable Price
ORBIMED ADVISORS LLC4,180,7680.48%No changeOther
BLACKROCK INC.3,905,7130.00057%14.56%Other
RENAISSANCE TECHNOLOGIES LLC1,459,5030.01%-13.74%Other
DUQUESNE FAMILY OFFICE LLC659,7500.11%No changeOther
D. E. SHAW & CO., INC.30,6330.00015%-92.96%Other
GEODE CAPITAL MANAGEMENT, LLC256,1440.00015%0.33%Other
TUDOR INVESTMENT CORP ET AL20,1050.00093%ExitedEvent Driven, Other
BALYASNY ASSET MANAGEMENT L.P.14,8530.00016%NewEvent Driven
FISHER ASSET MANAGEMENT, LLC2730%ExitedOther
CHANGE IN SHARES OUTSTANDING FOR ABCELLERA BIOLOGICS INC
STOCK BUYBACKS FOR ABCELLERA BIOLOGICS INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
12/31/2023
09/30/2023
0.32%
1Q
12/31/2023
06/30/2023
0.52%
2Q
12/31/2023
03/31/2023
0.92%
3Q
12/31/2023
12/31/2022
-8.32%
4Q
12/31/2023
09/30/2022
-8.04%
5Q
12/31/2023
06/30/2022
2.01%
6Q
12/31/2023
03/31/2022
-6.76%
7Q
12/31/2023
12/31/2021
-4.22%
8Q
12/31/2023
09/30/2021
4.12%
9Q
12/31/2023
06/30/2021
6.69%
10Q
12/31/2023
03/31/2021
-9.33%
11Q
12/31/2023
12/31/2020
10.37%
12Q
12/31/2023
09/30/2020
89.75%
13Q
12/31/2023
06/30/2020
11.35%
14Q
Load More

Period of Report: 12/31/2023

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
09/30/2023
0.32%
1Q
06/30/2023
0.52%
2Q
03/31/2023
0.92%
3Q
12/31/2022
-8.32%
4Q
09/30/2022
-8.04%
5Q
06/30/2022
2.01%
6Q
03/31/2022
-6.76%
7Q
12/31/2021
-4.22%
8Q
09/30/2021
4.12%
9Q
06/30/2021
6.69%
10Q
03/31/2021
-9.33%
11Q
12/31/2020
10.37%
12Q
09/30/2020
89.75%
13Q
06/30/2020
11.35%
14Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ABCELLERA BIOLOGICS INC
LOADING...